Table 4 Kegg pathways enriched in segment 1 versus 4 (FDR < 5%)
Term | Gene Count | FDR % |
|---|---|---|
hsa01100:Metabolic pathways | 210 | 2.5E-14 |
hsa01200:Carbon metabolism | 35 | 2.8E-06 |
hsa01130:Biosynthesis of antibiotics | 51 | 1.0E-05 |
hsa04146:Peroxisome | 27 | 1.1E-04 |
hsa00564:Glycerophospholipid metabolism | 29 | 1.2E-04 |
hsa04975:Fat digestion and absorption | 17 | 5.7E-04 |
hsa00020:Citrate cycle (TCA cycle) | 14 | 0.003 |
hsa00260:Glycine, serine and threonine metabolism | 16 | 0.005 |
hsa00280:Valine, leucine and isoleucine degradation | 17 | 0.011 |
hsa04976:Bile secretion | 21 | 0.013 |
hsa03320:PPAR signaling pathway | 20 | 0.030 |
hsa00640:Propanoate metabolism | 12 | 0.041 |
hsa00071:Fatty acid degradation | 15 | 0.091 |
hsa04931:Insulin resistance | 25 | 0.212 |
hsa04923:Regulation of lipolysis in adipocytes | 16 | 0.437 |
hsa00620:Pyruvate metabolism | 13 | 0.553 |
hsa00630:Glyoxylate and dicarboxylate metabolism | 10 | 1.674 |
hsa01212:Fatty acid metabolism | 13 | 3.191 |
hsa04930:Type II diabetes mellitus | 13 | 3.191 |
hsa04973:Carbohydrate digestion and absorption | 12 | 3.218 |
hsa00410:Beta-Alanine metabolism | 10 | 3.666 |
hsa00270:Cysteine and methionine metabolism | 11 | 3.888 |
hsa02010:ABC transporters | 12 | 4.744 |